Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAbbreviations and acronyms used in this report
Abrir esta carpeta y ver su contenidoOpening ceremony
Cerrar esta carpetaHerbal medicines
Ver el documentoCurrent status of traditional Chinese medicines in China
Ver el documentoRegulation of traditional Chinese medicines in Hong Kong, China
Ver el documentoProposed regulations for natural health products in Canada
Ver el documentoHow regulation of herbal medicines was established in Thailand
Ver el documentoHerbal medicine in the Islamic Republic of Iran
Ver el documentoTraditional herbal medicines: an update on European Union activities
Ver el documentoRegulation of herbal medicines in Ghana
Ver el documentoRecommendations
Abrir esta carpeta y ver su contenidoKeynote address
Abrir esta carpeta y ver su contenidoSafety of blood-derived products
Abrir esta carpeta y ver su contenidoAntimicrobial resistance - new initiatives
Abrir esta carpeta y ver su contenidoHarmonization I
Abrir esta carpeta y ver su contenidoHarmonization II
Abrir esta carpeta y ver su contenidoProtection of trial subjects in clinical trials
Abrir esta carpeta y ver su contenidoRegulating biotechnology products
Abrir esta carpeta y ver su contenidoRegulatory challenges: health sector reform and drug regulatory capacity
Abrir esta carpeta y ver su contenidoAccess to drugs and vaccines I
Abrir esta carpeta y ver su contenidoAccess to drugs and vaccines II
Abrir esta carpeta y ver su contenidoCounterfeit pharmaceutical products
Abrir esta carpeta y ver su contenidoHomoeopathy
Abrir esta carpeta y ver su contenidoSafety monitoring
Abrir esta carpeta y ver su contenidoE-Commerce
Abrir esta carpeta y ver su contenidoCurrent topics
Abrir esta carpeta y ver su contenidoRegulatory challenges of new technologies
Ver el documentoList of participants
Ver el documentoBack cover
 

How regulation of herbal medicines was established in Thailand

Ms Yupin Lawanprasert, Thailand

Herbal medicines play an important role in the everyday life of the Thai people. The use of herbal medicines has increased remarkably in line with the global trend of people returning to natural therapies. The Government and authorities concerned have taken part in the promotion and regulation of local herbal medicines in order to ensure that their quality, efficacy and safety meet international requirements and that they are used rationally. Manufacturers are also encouraged by the Government to improve their production standards to meet the requirements of Good Manufacturing Practices (GMP) and to conform to the higher specifications needed for the global market.

Under the Drug Act, herbal medicines are classified into four categories:

• herbal household remedies;
• traditional herbal medicines;
• modern herbal medicines;
• new drugs.


The Drug Act requires that any person who wishes to produce, sell or import drugs into Thailand must obtain a licence from the Food and Drug Administration (FDA) of Thailand. Herbal medicinal products must be registered before they can be produced or imported for marketing. An applicant must hold a manufacturing or importing licence granted by the FDA. The procedures for registration of herbal medicinal products are in two stages:

• application for permission to manufacture or import drug samples;
• application for drug registration.


Every application is evaluated by an expert subcommittee; if it is found that the product is proven to be safe and effective, it is registered.

Thailand has participated in the development of the ASEAN Guidelines on GMP for Herbal Medicines. GMP for herbal medicine is currently being implemented. It is recommended that herbal medicinal products should be manufactured in a GMP environment to ensure acceptable quality.

The main problem affecting the quality of traditional drugs is microbial contamination, since the use of synthetic preservatives is not permitted. Herbal medicinal products must therefore comply with the accepted limits for microbial stability specified in the Thai Pharmacopoeia.

Under the Drug Act, all materials used in the advertising and promotion of medicines, including herbal medicines, are subject to approval by the FDA of Thailand.

Thai traditional medicine is a valuable heritage of the Thai people. The Royal Thai Government has tried to revitalize its significance as an effective alternative treatment.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013